Lippman Evan bought TEVA
May 14, 2026 · Form 4 insider transaction
Lippman Evan bought 11,841 shares of Teva Pharmaceutical Industries Limited, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
11,841
Price
N/A
Total value
N/A
InsiderLippman Evan
RoleOfficer
SecurityOrdinary Shares
Transaction codeM: Option exercise
Transaction dateMay 14, 2026
Filing dateMay 18, 2026
Shares owned after11,841
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.; Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.